Karen Briley‐Sæbø

3.6k total citations
53 papers, 2.8k citations indexed

About

Karen Briley‐Sæbø is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Karen Briley‐Sæbø has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Karen Briley‐Sæbø's work include Advanced MRI Techniques and Applications (22 papers), Cerebrovascular and Carotid Artery Diseases (18 papers) and MRI in cancer diagnosis (17 papers). Karen Briley‐Sæbø is often cited by papers focused on Advanced MRI Techniques and Applications (22 papers), Cerebrovascular and Carotid Artery Diseases (18 papers) and MRI in cancer diagnosis (17 papers). Karen Briley‐Sæbø collaborates with scholars based in United States, Norway and Sweden. Karen Briley‐Sæbø's co-authors include Zahi A. Fayad, Venkatesh Mani, Juan Gilberto S. Aguinaldo, Edward A. Fisher, Fabien Hyafil, Willem J. M. Mulder, Vardan Amirbekian, Valentı́n Fuster, Esad Vucic and Juan C. Frías and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nano Letters.

In The Last Decade

Karen Briley‐Sæbø

53 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Briley‐Sæbø United States 30 996 743 689 604 532 53 2.8k
Esad Vucic United States 22 756 0.8× 459 0.6× 474 0.7× 658 1.1× 445 0.8× 35 2.3k
Todd A. Williams United States 18 752 0.8× 512 0.7× 525 0.8× 336 0.6× 481 0.9× 29 2.0k
Susanne Wagner Germany 31 828 0.8× 609 0.8× 934 1.4× 349 0.6× 486 0.9× 79 2.5k
Patrick M. Winter United States 32 1.7k 1.7× 1.2k 1.7× 1.3k 1.9× 628 1.0× 1.1k 2.0× 62 4.3k
Paula Jacobs United States 28 1.2k 1.2× 1.3k 1.7× 1.2k 1.8× 474 0.8× 542 1.0× 63 3.9k
Rafael T. M. de Rosales United Kingdom 34 871 0.9× 846 1.1× 990 1.4× 427 0.7× 1.0k 1.9× 79 3.6k
Ralph W. Fuhrhop United States 17 667 0.7× 436 0.6× 748 1.1× 245 0.4× 393 0.7× 33 1.8k
Ömer Aras United States 29 633 0.6× 207 0.3× 472 0.7× 873 1.4× 688 1.3× 109 3.0k
Juan C. Frías Spain 19 406 0.4× 345 0.5× 249 0.4× 300 0.5× 459 0.9× 47 1.9k
Eyk Schellenberger Germany 26 653 0.7× 523 0.7× 833 1.2× 190 0.3× 772 1.5× 56 2.2k

Countries citing papers authored by Karen Briley‐Sæbø

Since Specialization
Citations

This map shows the geographic impact of Karen Briley‐Sæbø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Briley‐Sæbø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Briley‐Sæbø more than expected).

Fields of papers citing papers by Karen Briley‐Sæbø

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Briley‐Sæbø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Briley‐Sæbø. The network helps show where Karen Briley‐Sæbø may publish in the future.

Co-authorship network of co-authors of Karen Briley‐Sæbø

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Briley‐Sæbø. A scholar is included among the top collaborators of Karen Briley‐Sæbø based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Briley‐Sæbø. Karen Briley‐Sæbø is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Briley‐Sæbø, Karen, Calvin Yeang, Joseph L. Witztum, & Sotirios Tsimikas. (2014). Imaging of Oxidation-Specific Epitopes with Targeted Nanoparticles to Detect High-Risk Atherosclerotic Lesions: Progress and Future Directions. Journal of Cardiovascular Translational Research. 7(8). 719–736. 14 indexed citations
2.
Eisenstein, Samuel, Brian A. Coakley, Karen Briley‐Sæbø, et al.. (2013). Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy. Cancer Research. 73(16). 5003–5015. 64 indexed citations
3.
Briley‐Sæbø, Karen, Young‐Seok Cho, Sung Kee Ryu, et al.. (2012). In Vivo Detection of Oxidation-Specific Epitopes in Atherosclerotic Lesions Using Biocompatible Manganese Molecular Magnetic Imaging Probes. Journal of the American College of Cardiology. 59(6). 616–626. 45 indexed citations
4.
Purushothaman, K‐Raman, Meerarani Purushothaman, Andrew P. Levy, et al.. (2012). Increased Expression of Oxidation-Specific Epitopes and Apoptosis Are Associated With Haptoglobin Genotype. Journal of the American College of Cardiology. 60(2). 112–119. 29 indexed citations
5.
Lipinski, Michael J., Juan C. Frías, Vardan Amirbekian, et al.. (2009). Macrophage-Specific Lipid-Based Nanoparticles Improve Cardiac Magnetic Resonance Detection and Characterization of Human Atherosclerosis. JACC. Cardiovascular imaging. 2(5). 637–647. 70 indexed citations
6.
Cormode, David P., Frédéric Chaubet, Karen Briley‐Sæbø, et al.. (2009). Tyrosine polyethylene glycol (PEG)‐micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque. Magnetic Resonance in Medicine. 62(5). 1195–1201. 29 indexed citations
7.
Briley‐Sæbø, Karen, Simonetta Geninatti Crich, David P. Cormode, et al.. (2009). High-Relaxivity Gadolinium-Modified High-Density Lipoproteins as Magnetic Resonance Imaging Contrast Agents. The Journal of Physical Chemistry B. 113(18). 6283–6289. 53 indexed citations
8.
Cormode, David P., Juan C. Frías, Yanqing Ma, et al.. (2009). HDL as a contrast agent for medical imaging. Clinical Lipidology. 4(4). 493–500. 27 indexed citations
9.
Mani, Venkatesh, Eric Adler, Karen Briley‐Sæbø, et al.. (2008). Serial in vivo positive contrast MRI of iron oxide‐labeled embryonic stem cell‐derived cardiac precursor cells in a mouse model of myocardial infarction. Magnetic Resonance in Medicine. 60(1). 73–81. 54 indexed citations
10.
Cormode, David P., Karen Briley‐Sæbø, Willem J. M. Mulder, et al.. (2008). An ApoA‐I Mimetic Peptide High‐Density‐Lipoprotein‐Based MRI Contrast Agent for Atherosclerotic Plaque Composition Detection. Small. 4(9). 1437–1444. 98 indexed citations
11.
Briley‐Sæbø, Karen, Venkatesh Mani, Fabien Hyafil, Jean‐Christophe Cornily, & Zahi A. Fayad. (2008). Fractionated feridex and positive contrast: In vivo MR imaging of atherosclerosis. Magnetic Resonance in Medicine. 59(4). 721–730. 50 indexed citations
12.
Cornily, Jean‐Christophe, Fabien Hyafil, Claudia Calcagno, et al.. (2008). Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin‐binding intravascular contrast agent and MRI. Journal of Magnetic Resonance Imaging. 27(6). 1406–1411. 25 indexed citations
13.
Chen, Wei, Esad Vucic, Willem J. M. Mulder, et al.. (2008). Incorporation of an apoE‐derived lipopeptide in high‐density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Contrast Media & Molecular Imaging. 3(6). 233–242. 69 indexed citations
14.
Briley‐Sæbø, Karen, Peter X. Shaw, Willem J. M. Mulder, et al.. (2008). Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes. Circulation. 117(25). 3206–3215. 125 indexed citations
15.
Briley‐Sæbø, Karen, Willem J. M. Mulder, Peter X. Shaw, et al.. (2007). Abstract 1454: Targeted Molecular Imaging Probes For In Vivo MR Detection Of Atherosclerotic Lesions Using Antibodies Against Oxidized Low Density Lipoprotein. Circulation. 116(suppl_16). 1 indexed citations
16.
Lipinski, Michael J., Vardan Amirbekian, Juan C. Frías, et al.. (2006). MRI to detect atherosclerosis with gadolinium‐containing immunomicelles targeting the macrophage scavenger receptor. Magnetic Resonance in Medicine. 56(3). 601–610. 116 indexed citations
17.
Mani, Venkatesh, Karen Briley‐Sæbø, Fabien Hyafil, & Zahi A. Fayad. (2006). Feasibility of in vivo identification of endogenous ferritin with positive contrast MRI in rabbit carotid crush injury using GRASP. Magnetic Resonance in Medicine. 56(5). 1096–1106. 30 indexed citations
18.
Kellar, Kenneth E., Dennis K. Fujii, Wolfgang Günther, et al.. (2002). Important Considerations in the Design of Iron Oxide Nanoparticles as Contrast Agents for Tl-Weighted MRI and MRA. Academic Radiology. 9(1). S34–S37. 17 indexed citations
19.
Kellar, Kenneth E., Dennis K. Fujii, Wolfgang Günther, et al.. (2000). NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive‐contrast MR angiography. Journal of Magnetic Resonance Imaging. 11(5). 488–494. 4 indexed citations
20.
Kellar, Kenneth E. & Karen Briley‐Sæbø. (1998). Phantom Standards With Temperature- and Field-Independent Relaxation Rates for Magnetic Resonance Imaging. Investigative Radiology. 33(8). 472–479. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026